The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
Abstract
Here we report that chromogranins, components of neurosecretory vesicles, interact with mutant forms of superoxide dismutase (SOD1) that are linked to amyotrophic lateral sclerosis (ALS), but not with wild-type SOD1. This interaction was confirmed by yeast two-hybrid screen and by co-immunoprecipitation assays using either lysates from Neuro2a cells coexpressing chromogranins and SOD1 mutants or lysates from spinal cord of ALS mice. Confocal and immunoelectron microscopy revealed a partial colocalization of mutant SOD1 with chromogranins in spinal cord of ALS mice. Mutant SOD1 was also found in immuno-isolated trans-Golgi network and in microsome preparations, suggesting that it can be secreted. Indeed we report evidence that chromogranins may act as chaperone-like proteins to promote secretion of SOD1 mutants. From these results, and our finding that extracellular mutant SOD1 can trigger microgliosis and neuronal death, we propose a new ALS pathogenic model based on the toxicity of secreted SOD1 mutants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Protein aggregates released into the extracellular space together with DAMPs released from damaged neurons induce microglia activation and proinflammatory cytokines releasing.20,83,84”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [84]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,131
Self-citationZhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O’Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis
Wiedau‐Pazos, M., Goto, J. J., Rabizadeh, S., Gralla, E. B., Roe, J. A., Lee, M. K., Valentine, J. S., & Bredesen, D. E. (1996) · Science · doi:10.1126/science.271.5248.515 · Cited by 720
Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220417997 · Cited by 616
The mystery of nonclassical protein secretion
Nickel, W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03577.x · Cited by 586
Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,120
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“Protein aggregates released into the extracellular space together with DAMPs released from damaged neurons induce microglia activation and proinflammatory cytokines releasing.(20,83,84) Persistent inflammation damages neurons directly and exacerbates ALS(78,85) (Fig.”
BackgroundALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
Superoxide dismutases and superoxide reductases
Sheng, Y., Abreu, I. A., Cabelli, D. E., Maroney, M. J., Miller, A.-F., Teixeira, M., & Valentine, J. S. (2014) · Chemical Reviews · doi:10.1021/cr4005296 · Cited by 1,081
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Astrocyte dysfunction in neurological disorders: a molecular perspective
Seifert, G., Schilling, K., & Steinhäuser, C. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1870 · Cited by 811
Role of Axonal Transport in Neurodegenerative Diseases
Vos, K. J. D., Grierson, A. J., Ackerley, S., & Miller, C. C. J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.061307.090711 · Cited by 767
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
Bosco, D. A., Morfini, G. A., Karabacak, M., Song, Y., Gros‐Louis, F., Pasinelli, P., Goolsby, H., Fontaine, B. A., Lemay, N., McKenna-Yasek, D. M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2660 · Cited by 685
Self-citationDisturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622
“The mode of cell-to-cell transfer is unclear,(39) but at least a-synuclein and SOD1 are secreted into the cell medium.(89,90) Furthermore, tau and a-synuclein have been measured at robust levels in the cerebrospinal fluid, suggesting secretion of these proteins in vivo.”
BackgroundMicroglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
The structural biochemistry of the superoxide dismutases
Perry, J. J. P., Shin, D. S., Getzoff, E. D., & Tainer, J. A. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.004 · Cited by 581
Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, G., Cuervo, A. M., Brown, R. H., & Glimcher, L. H. (2009) · Genes & Development · doi:10.1101/gad.1830709 · Cited by 530
Nishitoh, H., Kadowaki, H., Nagai, A., Maruyama, T., Yokota, T., Fukutomi, H., Noguchi, T., Matsuzawa, A., Takeda, K., & Ichijo, H. (2008) · Genes & Development · doi:10.1101/gad.1640108 · Cited by 530
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
Turner, B. J., & Talbot, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 524
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells
Münch, C., O’Brien, J., & Bertolotti, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017275108 · Cited by 475
Marchetto, M. C. N., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G., & Gage, F. H. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.001 · Cited by 475
The propagation of prion-like protein inclusions in neurodegenerative diseases
Goedert, M., Clavaguera, F., & Tolnay, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.04.003 · Cited by 472
Endoplasmic reticulum dysfunction in neurological disease
Roussel, B. D., Kruppa, A. J., Miranda, E., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70238-7 · Cited by 441
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
Lobsiger, C. S., & Cleveland, D. W. (2007) · Nature Neuroscience · doi:10.1038/nn1988 · Cited by 448
Beers, D. R., Henkel-Tigges, J., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 439
Gould, T. W., Buss, R. R., Vinsant, S. L., Prevette, D. M., Sun, W., Knudson, C. M., Milligan, C., & Oppenheim, R. W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2315-06.2006 · Cited by 397
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
Polymenidou, M., & Cleveland, D. W. (2011) · Cell · doi:10.1016/j.cell.2011.10.011 · Cited by 382
Microglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
RetractedThe Extended Granin Family: Structure, Function, and Biomedical Implications
Bartolomucci, A., Possenti, R., Mahata, S. K., Fischer‐Colbrie, R., Loh, Y. P., & Salton, S. R. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0027 · Cited by 355
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 332
Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
Kaur, S. J., McKEOWN, S. R., & Rashid, S. (2015) · Gene · doi:10.1016/j.gene.2015.11.049 · Cited by 339
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Israelson, A., Arbel, N., Cruz, S. D., Ilieva, H. S., Yamanaka, K., Shoshan‐Barmatz, V., & Cleveland, D. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.019 · Cited by 329
Kikuchi, H., Almer, G., Yamashita, S., Guégan, C., Nagai, M., Xu, Z., Sosunov, A. A., McKhann, G. M., & Przedborski, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509227103 · Cited by 327
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 309
Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury
Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288
Self-citationProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 294
Jang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281
Genetics of familial amyotrophic lateral sclerosis
Valdmanis, P. N., & Rouleau, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296811.19811.db · Cited by 286
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
RetractedSelective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
Velde, C. V., Miller, T. M., Cashman, N. R., & Cleveland, D. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712209105 · Cited by 287
Basso, M., Pozzi, S., Tortarolo, M., Fiordaliso, F., Bisighini, C., Pasetto, L., Spaltro, G., Lidonnici, D., Gensano, F., Battaglia, E., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425066 · Cited by 295
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells
Grad, L. I., Guest, W. C., Yanai, A., Pokrishevsky, E., O’Neill, M. A., Gibbs, E., Semenchenko, V., Yousefi, M., Wishart, D. S., Plotkin, S. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102645108 · Cited by 281
FTD and ALS: A Tale of Two Diseases
Ferrari, R., Kapogiannis, D., Huey, E. D., & Momeni, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563700 · Cited by 285
D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., & Aiso, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601840 · Cited by 269
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
Wu, D., Ré, D. B., Nagai, M., Ischiropoulos, H., & Przedborski, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603670103 · Cited by 258
How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?
SHAW, B., & Valentine, J. S. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.005 · Cited by 256
Ezzi, S. A., Urushitani, M., & Julien, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04531.x · Cited by 263
Self-citationAn emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
Rotunno, M. S., & Bosco, D. A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00253 · Cited by 256
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Zhao, W., Beers, D. R., Bell, S., Wang, J., Wen, S., Baloh, R. H., & Appel, S. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.019 · Cited by 241
Urushitani, M., Ezzi, S. A., & Julien, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606201104 · Cited by 237
Self-citationGomes, C., Keller, S., Altevogt, P., & Costa, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.024 · Cited by 228
Protein folding stress in neurodegenerative diseases: a glimpse into the ER
Matus, S., Glimcher, L. H., & Hetz, C. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.01.003 · Cited by 234
Kabuta, T., Suzuki, Y., & Wada, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603337200 · Cited by 220
Inflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 217
Modelling amyotrophic lateral sclerosis: progress and possibilities
Damme, P. V., Robberecht, W., & Bosch, L. V. D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029058 · Cited by 225
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213
Gros‐Louis, F., Soucy, G., Larivière, R., & Julien, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06683.x · Cited by 189
Self-citationChen, H.-J., Anagnostou, G., Chai, A., Withers, J., Morris, A. G., Adhikaree, J., Pennetta, G., & de Belleroche, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161398 · Cited by 196
Lobsiger, C. S., Boillée, S., McAlonis‐Downes, M., Khan, A. M., Feltri, M. L., Yamanaka, K., & Cleveland, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813339106 · Cited by 201
SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology
Bunton-Stasyshyn, R. K. A., Saccon, R. A., Fratta, P., & Fisher, E. (2014) · The Neuroscientist · doi:10.1177/1073858414561795 · Cited by 192
The microglial-motoneuron dialogue in ALS.
Appel, S. H., Zhao, W., Beers, D. R., & Henkel-Tigges, J. (2011) · Europe PMC (PubMed Central) · Cited by 179
Astrocyte function and role in motor neuron disease: A future therapeutic target?
Blackburn, D. J., Sargsyan, S. A., Monk, P. N., & Shaw, P. J. (2009) · Glia · doi:10.1002/glia.20848 · Cited by 187
Zhong, Z., Ilieva, H., Hallagan, L., Bell, R., Singh, I., Paquette, N., Thiyagarajan, M., Deane, R., Fernandez, J. A., Lane, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38476 · Cited by 176
Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia
Xiao, Q., Zhao, W., Beers, D. R., Yen, A. A., Xie, W., Henkel, J. S., & Appel, S. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04677.x · Cited by 174
Parone, P. A., Cruz, S. D., Han, J. S., McAlonis‐Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 188
IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients
Fiala, M., Chattopadhay, M., Cava, A. L., Tse, E., Liu, G., Lourenço, E. V., Eskin, A., Liu, P. T., Magpantay, L. I., Tse, S., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-76 · Cited by 180
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
Kawamata, H., & Manfredi, G. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.003 · Cited by 187
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
Jablonka, S., Beck, M., Lechner, B. D., Mayer, C., & Sendtner, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703187 · Cited by 172
Kawamata, H., & Manfredi, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3212 · Cited by 171
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Sadier, N. S. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 174
The Cu, Zn Superoxide Dismutase: Not Only a Dismutase Enzyme
Mondola, P., Damiano, S., Sasso, A., & Santillo, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00594 · Cited by 166
Remondelli, P., & Renna, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00187 · Cited by 174
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders
Hahnen, E., Hauke, J., Tränkle, C., Eyüpoglu, I. Y., Wirth, B., & Blümcke, I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.169 · Cited by 167
Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases
Cao, S. S., Luo, K. L., & Shi, L. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25098 · Cited by 163
Transgenic mouse models of amyotrophic lateral sclerosis
Julien, J., & Križ, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.006 · Cited by 162
Self-citationSon, M., Puttaparthi, K., Kawamata, H., Rajendran, B., Boyer, P. J., Manfredi, G., & Elliott, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610923104 · Cited by 160
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Gowing, G., Philips, T., Wijmeersch, B. V., Audet, J., Dewil, M., Bosch, L. V. D., Billiau, A., Robberecht, W., & Julien, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3494-08.2008 · Cited by 159
Self-citationSOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS
Hayashi, Y., Homma, K., & Ichijo, H. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.006 · Cited by 160
SOD1, an unexpected novel target for cancer therapy.
Papa, L., Manfredi, G., & Germain, D. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.4 · Cited by 147
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Plouffe, V., Mohamed, N., Rivest‐McGraw, J., Bertrand, J., Lauzon, M., & Leclerc, N. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036873 · Cited by 159
Innate immunity in amyotrophic lateral sclerosis
Moisse, K., & Strong, M. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.001 · Cited by 144
Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis?
Kabashi, E., Valdmanis, P. N., Dion, P. A., & Rouleau, G. A. (2007) · Annals of Neurology · doi:10.1002/ana.21319 · Cited by 143
Lobsiger, C. S., Boillée, S., & Cleveland, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702230104 · Cited by 139
Wang, L., Popko, B., Tixier, E. N., & Roos, R. P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.010 · Cited by 136
Inflammation in ALS and SMA: Sorting out the good from the evil
Papadimitriou, D. A., Verche, V. L., Jacquier, A., Ikiz, B., Przedborski, S., & Ré, D. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 137
The unfolded protein response in familial amyotrophic lateral sclerosis
Wang, L., Popko, B., & Roos, R. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq546 · Cited by 132
Chia, R., Tattum, M. H., Jones, S., Collinge, J., Fisher, E., & Jackson, G. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010627 · Cited by 131
Joyce, P. I., Fratta, P., Fisher, E., & Acevedo‐Arozena, A. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9339-1 · Cited by 139
Kanouchi, T., Ohkubo, T., & Yokota, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301826 · Cited by 130
Interaction between pathogenic proteins in neurodegenerative disorders
Jellinger, K. A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01507.x · Cited by 132
Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics
Ryberg, H., An, J., Darko, S. W., Lustgarten, J. L., Jaffa, M., Gopalakrishnan, V., Lacomis, D., Cudkowicz, M., & Bowser, R. P. (2010) · Muscle & Nerve · doi:10.1002/mus.21683 · Cited by 128
Rodent models of TDP-43: Recent advances
Tsao, W., Jeong, Y. H., Lin, S. Z., Ling, J. P., Price, D. L., Chiang, P., & Wong, P. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.031 · Cited by 129
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Diversity of astroglial responses across human neurodegenerative disorders and brain aging
Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 133
Metadata
- Authors
- Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Université Laval (CA)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- Nature Neuroscience
- Published
- 2005-12-20
- Volume
- 9
- Issue
- 1
- Pages
- 108-118
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2034651824
- Semantic Scholar
- 6da103b1c172cd68887144303844e02b0c5552ff
- Cited by
- 419
- References
- 47
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 8 · 2021: 9 · 2020: 14 · 2019: 10 · 2018: 13 · 2017: 16 · 2016: 20 · 2015: 25 · 2014: 23 · 2013: 35 · 2012: 28
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- chromogranin, superoxide dismutase 1, SOD1 mutations, amyotrophic lateral sclerosis, protein secretion, neurosecretory granules, chaperone-like protein, trans-Golgi network, microglial activation, neuronal cell death, ALS pathogenesis, spinal cord
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Cells, Cultured, Chlorocebus aethiops, Chromogranins, Fluorescent Antibody Technique, Gliosis, Humans, Interneurons, Mice, Transgenic, Microsomes, Motor Neurons, Mutation, Plasmids, Spinal Cord, Subcellular Fractions, Superoxide Dismutase, Blotting, Western, Microscopy, Immunoelectron, 3T3 Cells, Protein Folding, Molecular Chaperones, COS Cells, Immunoprecipitation, Mice, Chromogranin A, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review